| Gene symbol | MUC1 | Synonyms | ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3, EMA, H23AG, KL-6, MAM6, MCD, MCKD, MCKD1, MUC-1, MUC-1/SEC, MUC-1/X, MUC1/ZD, PEM, PEMT, PUM | Type of gene | protein-coding |
| Chromosome | 1 | Map location | 1q22 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | mucin 1, cell surface associated | ||||
| GTO ID | GTC1626 |
| Trial ID | NCT02839954 |
| Disease | Brain Glioma | Stomach Cancer | Pancreatic Carcinoma | Lung Non-Small Cell Carcinoma | Triple-Receptor Negative Breast Cancer | Hepatocellular Carcinoma | Colorectal Carcinoma |
| Altered gene | MUC1 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-NK cell |
| Treatment | MUC1 CAR-NK cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Unknown |
| Title | CAR-pNK Cell Immunotherapy in MUC1 Positive Relapsed or Refractory Solid Tumor |
| Year | 2016 |
| Country | China |
| Company sponsor | PersonGen BioTherapeutics (Suzhou) Co., Ltd. |
| Cohort 1 | |||||||||||
|
|||||||||||